CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma | Zendy

Rosa Coelho | Zendy; Marco Silva | Zendy; Eduardo RodriguesPinto | Zendy; Hélder Cardoso | Zendy; Susana Lopes | Zendy; Pedro Pereira | Zendy; Filipe VilasBoas | Zendy; João SantosAntunes | Zendy; José CostaMaia | Zendy; Guilherme Macedo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CA 19-9 as a Marker of Survival and a Predictor of Metastization in Cholangiocarcinoma

Author(s) -

Rosa Coelho,

Marco Silva,

Eduardo RodriguesPinto,

Hélder Cardoso,

Susana Lopes,

Pedro Pereira,

Filipe VilasBoas,

João SantosAntunes,

José CostaMaia,

Guilherme Macedo

Publication year - 2017

Publication title -

ge portuguese journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.321

H-Index - 9

eISSN - 2341-4545

pISSN - 2387-1954

DOI - 10.1159/000452691

Subject(s) - medicine , gastroenterology , malignancy , multivariate analysis

Cholangiocarcinoma is the second most frequent primitive liver malignancy and is responsible for 3% of the malignant gastrointestinal neoplasms. The aims of this study were to determine the association of serum levels of CA 19-9 at diagnosis with other clinical data and serum liver function tests and to identify possible factors that influence the survival rates during follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research